Aiomics Joins the Norrsken Evolve Programme

We are proud to share that aiomics has been accepted into the Norrsken Evolve Program—an initiative that supports some of Europe’s most ambitious early-stage founders. Out of more than 3,000 applicants, just over a dozen start-ups were selected this year.

From the start, we’ve been deeply impressed by the program’s quality and spirit. The cohort brings together an outstanding group of founders tackling some of the most pressing challenges of our time, and the Norrsken team has created an atmosphere of psychological safety that makes honest exchange and collaboration possible.

For aiomics, this experience has already proven invaluable. The support is tailored, hands-on, and practical—touching everything from fundraising and go-to-market strategy to organizational culture. It’s rare to find a setting where early-stage founders can test ideas, receive unfiltered feedback, and gain access to world-class mentors and peers at the same time.

Norrsken describes its mission clearly: “It is time for Europe to step up. We support early-stage founders who will build the resilient and sustainable future our continent needs.” That conviction resonates strongly with our own. At aiomics, we exist to return healthcare providers to their calling—removing distractions, amplifying their expertise, and helping them reconnect with patients .

Being part of Norrsken Evolve strengthens our ability to deliver on this mission. It connects us with founders across industries who share the same determination: to leave a positive mark on the world and to turn today’s crises into tomorrow’s opportunities.

We are grateful to be on this journey, and we look forward to sharing more as we learn and grow alongside this remarkable community.